8-KItem 5.02 · Officer/Director Change
Labcorp’s Megan Bailey to Resign; Brian Caveney to Lead Biopharma Laboratory Services
Filed with the SEC on · Summarized by InvestorsBot
Megan D. Bailey will resign as Labcorp’s executive vice president and president of Central Laboratories and International effective September 4, 2026. Effective September 1, Brian J. Caveney, M.D., will become executive vice president and president of Biopharma Laboratory Services while retaining his role as chief medical and scientific officer and responsibility for Early Development Research Laboratories and Central Laboratories.